CureVac Announces Resolution of Patent Litigation with Pfizer/BioNTech

BioNTech’s acquisition of CureVac will be implemented as planned

11-Aug-2025
AI-generated image

Symbolic image

CureVac N.V. announced that CureVac N.V. and an affiliate (together, “CureVac”), and an affiliate of GSK plc have entered into agreements with BioNTech SE and an affiliate (together, “BioNTech”) and Pfizer, Inc. to resolve and dismiss all pending patent litigation in the United States between the companies related to mRNA-based Covid-19 vaccines and to set a framework for resolving ongoing patent disputes outside the US upon closing of BioNTech’s acquisition of CureVac announced on June 12, 2025.

Under the terms of the agreements, CureVac and GSK will receive in aggregate a payment of $740 million as well as single-digit royalties on sales of COVID-19 vaccines in the United States going forward. Additionally, CureVac will receive $50 million from GSK for monetizing a portion of U.S. product royalties due under its existing license agreement announced on July 3, 2024.

Furthermore, as part of the settlement agreements, CureVac will grant BioNTech and Pfizer a non-exclusive license to manufacture, use, import into the U.S. and sell mRNA-based COVID-19 and/or influenza products. Such non-exclusive license will be expanded into a worldwide license upon the closing of BioNTech’s acquisition of CureVac.

Subject to regulatory approval, BioNTech’s acquisition of CureVac as announced on June 12, 2025 will be implemented as planned and its terms will remain unaffected.

Other news from the department politics & laws

Most read news

More news from our other portals

Last viewed contents

Ibidi Awarded With the German bAV Prize 2023

Ibidi Awarded With the German bAV Prize 2023

Using AI as an exam tutor - Artificial intelligence is set to help human examinees study more effectively

Using AI as an exam tutor - Artificial intelligence is set to help human examinees study more effectively

EXIST start-up grant for virtual reality laboratory training - "Wet-Lab-VR": Virtual reality technology revolutionises training for molecular biology laboratories

EXIST start-up grant for virtual reality laboratory training - "Wet-Lab-VR": Virtual reality technology revolutionises training for molecular biology laboratories

Sustainable Plastics from Plants - Innovative interdisciplinary education model

Sustainable Plastics from Plants - Innovative interdisciplinary education model

How immune cells become accomplices of tumors - Langener Wissenschaftspreis awarded to DKFZ researcher Daniel Kirschenbaum

How immune cells become accomplices of tumors - Langener Wissenschaftspreis awarded to DKFZ researcher Daniel Kirschenbaum

How the biological clock ticks in the female reproductive tract - Breakthrough of the Year Award 2025 for Ângela Gonçalves

How the biological clock ticks in the female reproductive tract - Breakthrough of the Year Award 2025 for Ângela Gonçalves

Boehringer Ingelheim announces change in the company management - Harsha Deshmukh has been appointed as a member of the Executive Board with responsibility for IT and Global Business Services with effect from February 1, 2026

Boehringer Ingelheim announces change in the company management - Harsha Deshmukh has been appointed as a member of the Executive Board with responsibility for IT and Global Business Services with effect from February 1, 2026

RNA Healer receives around one million euros for the development of a liver fibrosis therapy - MHH project wins start-up funding competition organised by Lower Saxony research incubator Institute for Biomedical Translation Lower Saxony.

RNA Healer receives around one million euros for the development of a liver fibrosis therapy - MHH project wins start-up funding competition organised by Lower Saxony research incubator Institute for Biomedical Translation Lower Saxony.

New active ingredients for the treatment of heart failure - NRW-wide HI-FIVE research project launched

New active ingredients for the treatment of heart failure - NRW-wide HI-FIVE research project launched

Smart sensor tag protects sensitive goods

Smart sensor tag protects sensitive goods

Beverage industry relies on enzymatic PET recycling from CARBIOS - New purchase agreements bring French biotech company closer to production launch

Beverage industry relies on enzymatic PET recycling from CARBIOS - New purchase agreements bring French biotech company closer to production launch

Gempex and msg industry advisors cooperate in the field of AI-supported services in the GMP-regulated environment - Quality assurance more efficient, targeted and secure

Gempex and msg industry advisors cooperate in the field of AI-supported services in the GMP-regulated environment - Quality assurance more efficient, targeted and secure